CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents.
Becherini P, Soncini D, Ravera S, Gelli E, Martinuzzi C, Giorgetti G, Cagnetta A, Guolo F, Ivaldi F, Miglino M, Aquino S, Todoerti K, Neri A, Benzi A, Passalacqua M, Nencioni A, Perrotta I, Gallo Cantafio ME, Amodio N, De Flora A, Bruzzone S, Lemoli RM, Cea M.
Becherini P, et al. Among authors: gelli e.
Antioxidants (Basel). 2023 Feb 15;12(2):494. doi: 10.3390/antiox12020494.
Antioxidants (Basel). 2023.
PMID: 36830052
Free PMC article.